Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-14

Hwh International Inc. (ESYN) Stock Forecast Oct. 14, 2026

Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Top 35% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $16M small-cap · #6 of 6 peers
Summary

Hwh International Inc. (ESYN) stock forecast summary

Our AI ranks Hwh International Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Hwh International Inc. is a small-cap company with a market capitalization of $16M. It ranks number 6 by market capitalization among the 6 Wholesale-Drugs, Proprietaries & Druggists' Sundries issuers in our coverage with a current forecast. Its Net Margin of -657.6% is the lowest of the 8 peers that report one.

A per-ticker accuracy statistic for ESYN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, ESYN included.

Follow ESYN free
Price

ESYN price chart and AI forecast

ESYN
Cross-section · 2026-10-13

How ESYN ranks among 5379 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Hwh International Inc. (ESYN) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Wholesale-Drugs, Proprietaries & Druggists' Sundries peers listed below that report each metric.

Valuation & Market

MetricESYNIndustry medianRank
Market Cap $16M $28.62B 6/6
P/B Ratio 5.74x – –
Book Value/Share $0.35 – –
Revenue/Share $0.05 – –
FCF/Share $-0.12 – –

Profitability & Margins

MetricESYNIndustry medianRank
ROE -93.7% – –
ROA -56.8% -8.2% 7/8
Gross Margin 59.2% 9.4% 3/7
Net Margin -657.6% -7.6% 8/8
EBT Margin -659.8% -0.6% 8/8
Tax Rate -1.9% – –

Financial Health

MetricESYNIndustry medianRank
Current Ratio 1.82x 1.05x 2/7
Quick Ratio 1.81x 0.68x 1/7
D/E Ratio 0.63x – –
Financial Leverage 1.65x – –
Working Capital $1M $1M 4/7

Cash Flow

MetricESYNIndustry medianRank
Operating Cash Flow -$940K $217M 6/8
Free Cash Flow -$960K $322M 5/5
Capital Spending -$20K -$62M 1/5
FCF/Sales -245.1% 1.2% 5/5
CapEx/Sales 4.8% 1.2% 1/5

Operational Efficiency

MetricESYNIndustry medianRank
Asset Turnover 0.09x 1.82x 5/5
Receivables Turnover 96.2x 28.1x 1/5
Inventory Turnover 93.8x 13.8x 1/7
Fixed Assets Turnover 26.6x 26.6x 3/5
Days Sales Outstanding 4 days 13 days 5/5
Days Inventory 4 days 27 days 7/7

Income Statement

MetricESYNIndustry medianRank
Total Revenue $0.00M $5.20B 5/5
Net Income -$2M $81M 5/8
Cost of Goods Sold $140K $792M 8/8

Dividend & Shareholder Information

MetricESYNIndustry medianRank
Shares Outstanding 8M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$3M66.9% of assets
Cash & Short-term Investments$2M34.0% of assets
Accounts Receivable$0.00M0.0% of assets
Inventory$0.00M0.0% of assets
Total Liabilities$2M38.5% of assets
Quarterly Financial Reports

ESYN quarterly financials and insider trading

Industry Peers · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Hwh International Inc. (ESYN) industry peers

Companies classified under the same SEC industry code as Hwh International Inc. (Wholesale-Drugs, Proprietaries & Druggists' Sundries): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
ESYN Hwh International Inc. ▲ $16M – 5.7x
MCK Mckesson Corp ▶ $112.15B 24.4x –
COR Cencora, Inc. ▲ $62.99B 24.0x 20.7x
CAH Cardinal Health Inc ▶ $55.75B – –
HLF Herbalife Ltd. ▼ $1.49B 9.1x –
NUS Nu Skin Enterprises, Inc. ▶ $244M – 0.5x
COSM Cosmos Health Inc. ▲ N/A – –
STEK Stemtech Corp ▼ N/A – –

Where ESYN sits on the market map

Trade & Services · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Explore the map →
News

Hwh International Inc. (ESYN) stock news

Loading...

FAQ

Hwh International Inc. (ESYN) stock forecast FAQ

What is the Hwh International Inc. (ESYN) stock forecast?

Our AI ranks Hwh International Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Hwh International Inc. stock predictions?

A per-ticker accuracy statistic for ESYN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Hwh International Inc. forecasts updated?

Hwh International Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Which companies are Hwh International Inc.'s industry peers?

8 issuers in our coverage, ESYN included, share the SEC industry code Wholesale-Drugs, Proprietaries & Druggists' Sundries. The largest are: Mckesson Corp (MCK), Cencora, Inc. (COR), Cardinal Health Inc (CAH), Herbalife Ltd. (HLF), Nu Skin Enterprises, Inc. (NUS), Cosmos Health Inc. (COSM).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.